Population dynamics, consumer demand and an effective corporate tax cut are coalescing to make the UK healthcare sector an increasingly attractive proposition, says Newton Investment Management’s Paul Stephany.
Recent pre-election uncertainty is all about protection, says Smith & Williamson’s Mark Boucher, but consumer discretionary spending will carry on regardless.
The healthcare sector is immersed in an “unprecedented period of structural change” which is a reflection of shifting dynamics and technologies throughout the world. But rather than being a cause for concern, Stenham Asset Management gives reasons why we should be optimistic about healthcare funds
Many seem fond to talk up the “return of the stockpicker” but what about the age of the thematic investor?
Given that healthcare has been the joint-top equity sector this year, growing 18% since the start of 2013, it is unsurprising investors and fund managers alike are positioning themselves to take advantage of profit opportunities.
The opening paragraph in last Friday's Financial Times read: "A sell-off in equities, bonds and commodities yesterday [Thursday 20 June] fuelled fears that the world is entering a fresh phase of financial turbulence as the US Federal Reserve prepares to ease its large-scale asset purchases."
Polar Capital has made two new hires for its healthcare team as it looks to expand its range of healthcare investment products ahead of a predicted uptick in opportunities in the sector.
Stenham Asset Management has unveiled two fund of hedge funds focusing on the credit and healthcare equities.
Lombard Odier Investment Managers has appointed Bruce Turner to manage the healthcare portfolio strategy element of its 1798 Fundamental Strategies Fund and Global Equity Long/Short Fund.
Since the turn of the year, the defensive healthcare and biotech funds have given solid returns.
Polar Capital’s results showed assets under management jumped by 53% as profits rose three-fold.
